GI
VKTX icon

GAMMA Investing’s Viking Therapeutics VKTX Stock Holding History

GAMMA Investing’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$53.4K Buy
1,637
+239
+17% +$8.28K ﹤0.01% 2327
2026
Q2 		$54.5K Buy
1,398
+75
+6% +$2.42K ﹤0.01% 2240
2026
Q1 		$43K Buy
1,323
+128
+11% +$4.11K ﹤0.01% 2275
2025
Q4 		$42K Buy
1,195
+496
+71% +$17.6K ﹤0.01% 2189
2025
Q3 		$18.4K Buy
699
+95
+16% +$2.83K ﹤0.01% 2556
2025
Q2 		$16K Sell
604
-406
-40% -$10.7K ﹤0.01% 2575
2025
Q1 		$24.4K Buy
1,010
+748
+285% +$23.6K ﹤0.01% 2268
2024
Q4 		$10.5K Sell
262
-176
-40% -$10K ﹤0.01% 2583
2024
Q3 		$27.7K Buy
438
+243
+125% +$14.3K ﹤0.01% 1904
2024
Q2 		$10.3K Buy
195
+63
+48% +$4.13K ﹤0.01% 2237
2024
Q1 		$10.8K Buy
132
+26
+25% +$1.16K ﹤0.01% 2012
2023
Q4 		$2.56K Buy
+106
New +$1.39K ﹤0.01% 2497

Other funds holding VKTX

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
PP
Paladin Partners Hartland, Wisconsin $162M AUM 13.31% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $937M AUM 18.56% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

GAMMA Investing's VKTX Position: Q3 2026 in Review

GAMMA Investing increased its Viking Therapeutics (VKTX) stake by 17% in Q3 2026, buying an estimated $8.28K and bringing the position to 1,637 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

GAMMA Investing first reported a position in VKTX in Q4 2023 and has held it in 12 quarters since. The position peaked at $54.5K in Q2 2026. 11 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • GAMMA Investing held 1,637 shares of Viking Therapeutics worth $53.4K as of Q3 2026.
  • GAMMA Investing bought 239 Viking Therapeutics shares in Q3 2026, an estimated $8.28K.
  • Viking Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2327 holding.
  • GAMMA Investing first reported a position in Viking Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Viking Therapeutics position peaked at $54.5K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.